09/22/2023 /
New epilepsy research on CBD, a new genetic study, TSC, and more.
09/20/2023 /
Validated multiple differentially expressed genes (DEGs), such as glycine receptor subunit 2 and cholecystokinin, at the transcript and/or protein levels, supporting the relevance of these genes to CDKL5-regulated excitability.
09/19/2023 /
See the impact we have had over the past 25 years, watch UNITE recordings, get ready for Hamilton Unplugged and a Hamilton raffle!
09/13/2023 /
Here, we describe therapeutic strategies for modulating disease-associated RNA molecules and highlight the potential of RNA therapeutics for the treatment of different patient populations such as sporadic, drug-resistant epilepsy, and childhood monogenic epilepsies.
09/11/2023 /
Featuring the work of CURE Epilepsy’s PTE Initiative Massachusetts General Team. Delineate strategies developed to mitigate the substantial motion artifact that complicates high resolution imaging in large animals, including heartbeat-triggered high-speed image stack acquisition.
09/11/2023 /
“The medical cannabis research originated from the patient families and advocates in Colorado who have witnessed the positive effects of medical cannabis products.”
09/07/2023 /
The electrodes allowed doctors to find epilepsy networks in nearly 88 percent of patients.
09/07/2023 /
In 11 participants given the highest dose of 50 mg, increases in EEG spectral power were observed across all bands and distributed over all cortical brain regions.
09/06/2023 /
The researchers identified 26 distinct areas in our DNA that appear to be involved in epilepsy. This included 19 which are specific to a particular form of epilepsy called ‘genetic generalized epilepsy’ (GGE).
